Literature DB >> 26234373

Regulatory T Cells in Kidney Transplantation: New Directions?

F Braza1,2,3, M Durand1,2,3, N Degauque2,3, S Brouard2,3.   

Abstract

The contribution of regulatory T cells in the maintenance of kidney graft survival is of major interest. Although many experimental models suggest a role in the induction of graft tolerance, reproducing these findings in clinic is less clear. While modulation of the regulatory T cell response is a promising therapeutic concept in transplantation, a better understanding of function, phenotype and biology is needed to be able to optimally exploit these cells in order to induce graft tolerance. With this in mind, we review here the current understanding of the phenotypic-functional delineation of Tregs and how Tregs can contribute to graft survival. We highlight their potential role in long-term graft survival and kidney operational tolerance. We also discuss the mechanisms needed for the molecular development of regulatory T cells: A combination of FOXP3 molecular partners, epigenetic, metabolic, and posttranslational modifications are necessary to generate well-functioning regulatory T cells and maintain their core identify. We discuss how an improved understanding of these mechanisms will permit the identification of new potent therapeutic strategies to improve kidney graft survival. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Basic (laboratory) research/science; immunobiology; kidney transplantation/nephrology; lymphocyte biology; tolerance: clinical

Mesh:

Year:  2015        PMID: 26234373     DOI: 10.1111/ajt.13395

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  13 in total

1.  Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: The Promise and the Stumbling Blocks.

Authors:  Mohamed B Ezzelarab; Angus W Thomson
Journal:  Curr Transplant Rep       Date:  2016-10-25

Review 2.  Transplant trials with Tregs: perils and promises.

Authors:  Qizhi Tang; Flavio Vincenti
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

3.  RNA expression profiling of nonhuman primate renal allograft rejection identifies tolerance.

Authors:  R N Smith; M Matsunami; B A Adam; I A Rosales; T Oura; A B Cosimi; T Kawai; M Mengel; R B Colvin
Journal:  Am J Transplant       Date:  2018-02-17       Impact factor: 8.086

Review 4.  Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy.

Authors:  Kalpana Parvathaneni; Maha Abdeladhim; Kathleen P Pratt; David W Scott
Journal:  Transl Res       Date:  2017-06-09       Impact factor: 7.012

Review 5.  Burnstock oration - purinergic signalling in kidney transplantation.

Authors:  Karen M Dwyer
Journal:  Purinergic Signal       Date:  2022-04-26       Impact factor: 3.765

Review 6.  Immune monitoring as prerequisite for transplantation tolerance trials.

Authors:  K Behnam Sani; B Sawitzki
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

Review 7.  The Changing Landscape of Renal Inflammation.

Authors:  Thomas Ernandez; Tanya Norton Mayadas
Journal:  Trends Mol Med       Date:  2016-01-07       Impact factor: 11.951

8.  Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

Authors:  M B Ezzelarab; H Zhang; H Guo; L Lu; A F Zahorchak; R W Wiseman; M A Nalesnik; J K Bhama; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2016-03-17       Impact factor: 8.086

Review 9.  Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future Perspectives.

Authors:  Eman Shaban; George Bayliss; Deepak K Malhotra; Douglas Shemin; Li Juan Wang; Reginald Gohh; Lance D Dworkin; Rujun Gong
Journal:  Kidney Dis (Basel)       Date:  2018-07-31

10.  Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients.

Authors:  Mohamed B Ezzelarab; Hong Zhang; Kazuki Sasaki; Lien Lu; Alan F Zahorchak; Dirk J van der Windt; Helong Dai; Angelica Perez-Gutierrez; Jay K Bhama; Angus W Thomson
Journal:  Transplantation       Date:  2021-09-01       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.